1.Inpatient Parkinson’s care: Challenges and special considerations
Journal of Medicine University of Santo Tomas 2023;7(1):1144-1152
The hospital is often a haven for people in need of care. However, for people with Parkinson’s disease (PD), hospitalizations can turn into a nightmare. People with PD are admitted to the hospital more frequently than those without PD. Infections, metabolic changes, exposure to anesthesia, changes in medication regimen or new medication changes are some common factors that may worsen PD symptoms during hospitalization. More importantly, the inherent complexity of PD pathophysiology creates challenges in management. Therefore, understanding PD pathophysiology and recognizing care gaps enable optimization of inpatient care among this vulnerable population.
Parkinson Disease
;
Inpatients
3.Botulinum toxin treatment practice recommendations for movement disorders clinics during the COVID-19 pandemic
Roland Dominic G. Jamora ; Jeryl Ritzi T. Yu ; Adrian I. Espiritu ; Ryan M. Llorin ; Rosemarie M. Tiongson ; Arlene R. Ng
Acta Medica Philippina 2022;56(5):94-99
Background:
Due to the Coronavirus disease 2019 (COVID-19) pandemic, non-emergency services like botulinum toxin A (BoNT) injections were temporarily discontinued.
Objective:
We aimed to create standard practices that optimize the management of patients needing BoNT injections while ensuring both patients' and healthcare professionals' safety.
Methods:
We evaluated published guidelines and best practices to determine their applicability for BoNT injection during this pandemic. We then devised a decision tree algorithm for use in our hospital.
Results:
A decision tree algorithm has been formulated based on patient evaluation and risk stratification, triaging, the urgency of the procedure, and proper precautions on personal protective wear as appropriate for the procedure’s risk stratification.
Conclusion
The algorithm is in place to ensure the safety of both the patient and healthcare professional. It can be adopted and revised by other centers to suit their clinic needs.
Movement Disorders
;
COVID-19
;
Botulinum Toxins
;
Therapeutics
;
Pandemics